Here we examine the NAMPT expression in a large cohort of resected stage I/II pancreatic ductal adenocarcinomas (PDAs) and correlate its expression with clinical outcomes and pathologic features. The gene discussed is NAMPT; the disease is pancreatic ductal adenocarcinoma.